Both in Pharmaceuticals

Vogenx vs ARS Pharmaceuticals

Over the past year VOGX returned −36.6% and SPRY returned −35.9%; their daily moves had a correlation of 0.05.

VOGX −36.6% SPRY −35.9%Growth of $1, one year, split-adjusted
MetricVOGXSPRY
Price$20.74$3.05
Market cap$308.1M$303.3M
Today+2.42%−9.76%
1 month+13.8%−25.1%
6 months—−65.5%
Year to date—−73.8%
1 year—−64.6%
Revenue growth (YoY)—+114.2%
Gross margin—61.8%
Net margin—−185.2%
P/E (TTM)——
Price / sales—2.6×
Net cash—-$27.8M
Dividend yield——
Volatility (60d)—70.2%
Short % of float0.4%40.5%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

VOGX vs SPRY: Vogenx vs ARS Pharmaceuticals Stock Comparison | Gainbot